Sharechat Logo

South Canterbury Finance succession plan well underway, McLeod says

Thursday 30th July 2009

Text too small?

South Canterbury Finance, the finance company whose investment-grade credit is being supported by its biggest shareholder, has a succession plan underway which it expects to find shape before Christmas.

The company’s board is working on initiatives to replace major shareholder and chairman Alan Hubbard when he retires, and has kept ratings agency Standard & Poor’s abreast of the situation, chief executive Lachie McLeod told The Press newspaper.  

Two weeks ago, S&P placed the South Island-based finance company on creditwatch negative, which gives SCF a one-in-two chance of losing its BBB- credit rating, due to its deteriorating credit profile.

The company posted a $37 million loss before tax after it announced a $58 million writedown on non-performing investments and doubtful property assets.  Earlier this month, the ratings agency told BusinessWire that Hubbard’s backing helped underpin its investment grade ratings, and the Timaru millionaire injected NZ$40 million of new capital into SCF, as well as agreeing to underwrite any further impaired loans.  

McLeod told the Press any credit rating downgrade wouldn’t force the company to pay back a private placement by U.S. investors worth some US$100 million, but would result in them having to renegotiate the arrangement.  

 

Businesswire.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors